Injective (INJ) Price Prediction

By CMC AI
21 November 2026 03:29AM (UTC+0)
TLDR

INJ’s near term looks stormy; longer term depends on delivery.

  1. Veyra launch: The Nov. 24, 2026 upgrade could improve institutional trading and cross chain tools, if it launches cleanly and attracts use.

  2. RWA adoption: Tokenized assets and a U.S. listed INJ ETF offer growth paths, but sustained usage and fund inflows matter more than headlines.

  3. Risk off market: INJ is down 21.98% over seven days as crypto sentiment hits extreme fear, which could keep pressure on price.

Deep Dive

1. Veyra’s mainnet launch (Mixed Impact)

Overview: Veyra is scheduled for Nov. 24, 2026, following governance approval. It is planned to add cross chain asset transfers, request for quote trading for large orders, expanded atomic swaps, and real world asset infrastructure. A short pause in block production is expected during the upgrade; privacy features are groundwork, not part of this launch. (CoinMarketCap)

What this means: A smooth rollout could support confidence and enable more trading activity, potentially increasing demand for INJ. A disruption or weak adoption could instead turn the event into a short lived catalyst.

2. Adoption, token value and competition (Mixed Impact)

Overview: Injective reported more than $1.5 billion in tokenized mortgage loans on its network in November 2026. Its INJC staked ETF began trading on Nasdaq on Nov. 5, though early asset figures do not establish sustained investor inflows. Competition for tokenized finance remains intense. (TokenPost, CoinMarketCap)

What this means: More real usage could support network activity and INJ demand, but asset issuance alone does not guarantee token value capture. Watch transaction activity, trading volume, and ETF flows.

3. Market pressure and momentum (Bearish Impact)

Overview: As of Nov. 21, INJ was $6.19, down 8.90% in 24 hours and 21.98% in seven days. The broader crypto market was down 13.11% over seven days, with the Fear and Greed Index at 7, “Extreme fear.” INJ’s RSI readings were weak, while MACD remained negative. (CMC market data, CMC market overview)

What this means: Broad selling can outweigh project news in the near term. RSI near 31 on the seven day measure suggests selling pressure is heavy, but does not by itself confirm a reversal.

Conclusion

Veyra and adoption are potential medium term supports; weak sentiment and price momentum are immediate risks. For holders and traders, expect volatility and judge progress by real usage, not announcements alone.

Will Veyra launch smoothly on Nov. 24, and will network activity rise afterward?

CMC AI can make mistakes. Not financial advice.